SMTL ID : 4acm.1

CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain A: W.168, R.201, A.202, P.205 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.201, A:R.201, A:A.202 GOL.2: 3 residues within 4Å: Chain A: F.110, F.287, V.290 1 PLIP interactions: 1 interactions with chain A Water bridges: A:L.282

1 x 7YG: 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE(Non-covalent)

7YG.3: 20 residues within 4Å: Chain A: K.10, I.11, G.12, G.14, V.19, A.32, K.34, V.65, F.81, E.82, F.83, L.84, H.85, Q.86, D.87, K.90, Q.132, N.133, L.135, D.146 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.11, A:F.83, A:D.87, A:L.135 Hydrogen bonds: A:E.82, A:L.84, A:D.87, A:K.90 Water bridges: A:D.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Berg, S. et al., Discovery of novel potent and highly selective glycogen synthase kinase-3 beta (GSK3 beta ) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines. J. Med. Chem. (2012)

Release Date

2012-05-16

Peptides

CYCLIN-DEPENDENT KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CYCLIN-DEPENDENT KINASE 2

Related Entries With Identical Sequence